セリアック病治療薬の世界市場規模調査＆予測、薬剤別（一次治療、二次治療）、地域別分析、2022-2029年

セリアック病、セリアックスプルー、グルテン過敏性腸症は、小腸に影響を及ぼす消化器系の病気です。

グルテンを摂取すると、小腸で免疫反応が引き起こされます。セリアック病には、下痢、腹部膨満感、風、疲労、低血球（貧血）、骨粗しょう症など、さまざまな症状があります。セリアック病の罹患率の増加、セリアック病啓発プログラムへの投資の増加は、市場成長を促進する主要因です。

セリアック病の有病率の増加は、世界のセリアック病治療市場の拡大に寄与しています。例えば、Beyond Celiac Organizationによると、米国では133人に1人、つまり人口の約1％がセリアック病に罹患していると推定されています。また、シカゴ大学医学部セリアック病センターの推計によると、米国ではセリアック病は少なくとも300万人のアメリカ人に影響を及ぼすとされています。また、新興国地域のヘルスケア分野への投資の増加や、セリアック病治療薬に関する研究開発の活発化は、予測期間中、同市場に有利な成長見通しをもたらすと考えられます。しかし、医薬品承認のための厳しい規制の枠組みが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

セリアック病治療薬の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、ブランド製品の優位性と地域におけるセリアック病の発生率の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、老年人口やターゲット人口の増加、ヘルスケア部門の成長などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

市場における最近の進展

• 2019年8月、米国食品医薬品局（FDA）は、ActoBio Therapeutics社の経口ActoBiotics AG017カプセルの治験薬（IND）を承認しました。本新薬は、セリアック病の回復を目的とした経口生物学的製剤候補です。

世界市場レポートの範囲

• 過去データ：2019-2020-2021年
• 推計の基準年：2021年
• 予測期間：2022-2029年
• レポート範囲：収益予測、企業ランキング、競合情勢、成長要因、動向
• 地域別範囲：北米、欧州、アジア太平洋地域、ラテンアメリカ、世界のその他地域
• カスタマイズの範囲：レポートカスタマイズ（最大8名分の作業時間）を無料で提供。国別、地域別、セグメント別範囲の追加・変更。

本調査の目的は、近年における様々な分野・国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢などの詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • セリアック病治療薬市場、地域別、2019-2029年
  • セリアック病治療薬市場、薬剤別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 セリアック病治療薬の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 セリアック病治療薬の世界市場力学

• セリアック病治療薬市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • セリアック病の発症率の増加
    • セリアック病啓発プログラムへの投資の拡大
  • 市場の課題
    • 医薬品承認に関する厳しい規制の枠組み
  • マーケットオポチュニティ
    • 新興国におけるヘルスケア分野への投資の増加
    • セリアック病治療薬に関連する研究開発活動の活発化

第4章 セリアック病治療薬の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 最高の投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスクアセスメントCOVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 セリアック病治療薬の世界市場：薬物別

• マーケットスナップショット
• セリアック病治療薬の世界市場：薬剤別、性能別- ポテンシャル分析
• セリアック病治療薬の世界市場薬品別推定・予測2019-2029
• セリアック病治療薬市場、サブセグメント分析
  • 治療のファーストライン
  • 治療のセカンドライン

第7章 セリアック病治療薬の世界市場：地域別分析

• セリアック病治療薬市場、地域別マーケットスナップショット
• 北米
  • 米国
    • 医薬品別の推定・予測、2019年～2029年
  • カナダ
• 欧州セリアック病治療薬市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のセリアック病治療薬市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのセリアック病治療薬市場スナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第8章 競合情報

• トップ市場戦略
• 企業プロファイル
  • F. Hoffmann La Roche
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Merck & Co., Inc.
  • Johnson & Johnson
  • BiolineRx Ltd.
  • Pfizer Inc.
  • Innovate Biopharmaceuticals
  • ImmusanT, Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Immunomedics, Inc.

第9章 調査のプロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Celiac Disease Drugs Market, report scope
• TABLE 2. Global Celiac Disease Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Celiac Disease Drugs Market estimates & forecasts by Drugs 2019-2029 (USD Billion)
• TABLE 4. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 69. List of primary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Celiac Disease Drugs Market, research methodology
• FIG 2. Global Celiac Disease Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Celiac Disease Drugs Market, key trends 2021
• FIG 5. Global Celiac Disease Drugs Market, growth prospects 2022-2029
• FIG 6. Global Celiac Disease Drugs Market, porters 5 force model
• FIG 7. Global Celiac Disease Drugs Market, pest analysis
• FIG 8. Global Celiac Disease Drugs Market, value chain analysis
• FIG 9. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Celiac Disease Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Celiac Disease Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Celiac Disease Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Celiac Disease or celiac sprue or gluten-sensitive enteropathy is a digestive problem that affects small intestine. Consumption of gluten triggers an immune response in the small intestine. There are different symptoms of Celiac disease including diarrhoea, bloating, wind, fatigue, low blood count (anaemia) and osteoporosis among others. The increasing incidence of Celiac Disease and growing investments in celiac disease awareness programs are key factors driving the market growth.

The increasing prevalence of Celiac Disease is contributing towards the expansion of Global Celiac Disease Treatment Market. For instance - as per Beyond Celiac Organization - in the United States an estimated 1 in 133 Americans, or about 1% of the population, has celiac disease. Moreover, as per the University of Chicago Medicine's Celiac disease Center estimates - in USA Celiac disease affects at least 3 million Americans. Also, increasing investment in healthcare sector in developing region and rising R&D activities related to celiac disease drugs would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for drug approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Celiac Disease Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and increasing incidences of celiac diseases in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and the growing healthcare sector in the region.

Major market players included in this report are:

• F. Hoffmann-La Roche
• Merck & Co., Inc.
• Johnson & Johnson
• BiolineRx Ltd.
• Pfizer Inc.
• Innovate Biopharmaceuticals
• ImmusanT, Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Immunomedics, Inc.

Recent Developments in the Market:

• In August 2019, the US Food and Drug Administration (FDA) approved an investigational new drug (IND) for oral ActoBiotics AG017 capsules from ActoBio Therapeutics. This new drug is an oral biologic drug candidate for the reversal of celiac disease.

Global Celiac Disease Drugs Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Drugs, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs

• First Line of Treatment
• Second Line of Treatment

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Celiac Disease Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Celiac Disease Drugs Market, by Drugs, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Celiac Disease Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Celiac Disease Drugs Market Dynamics

• 3.1. Celiac Disease Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Celiac Disease
    • 3.1.1.2. Growing investments in celiac disease awareness programs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent regulatory framework for drug approval
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing investment in healthcare sector in developing region
    • 3.1.3.2. Rising R&D activities related to celiac disease drugs

Chapter 4. Global Celiac Disease Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Celiac Disease Drugs Market, by Drugs

• 6.1. Market Snapshot
• 6.2. Global Celiac Disease Drugs Market by Drugs, Performance - Potential Analysis
• 6.3. Global Celiac Disease Drugs Market Estimates & Forecasts by Drugs 2019-2029 (USD Billion)
• 6.4. Celiac Disease Drugs Market, Sub Segment Analysis
  • 6.4.1. First Line of Treatment
  • 6.4.2. Second Line of Treatment

Chapter 7. Global Celiac Disease Drugs Market, Regional Analysis

• 7.1. Celiac Disease Drugs Market, Regional Market Snapshot
• 7.2. North America Celiac Disease Drugs Market
  • 7.2.1. U.S. Celiac Disease Drugs Market
    • 7.2.1.1. Drugs breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Celiac Disease Drugs Market
• 7.3. Europe Celiac Disease Drugs Market Snapshot
  • 7.3.1. U.K. Celiac Disease Drugs Market
  • 7.3.2. Germany Celiac Disease Drugs Market
  • 7.3.3. France Celiac Disease Drugs Market
  • 7.3.4. Spain Celiac Disease Drugs Market
  • 7.3.5. Italy Celiac Disease Drugs Market
  • 7.3.6. Rest of Europe Celiac Disease Drugs Market
• 7.4. Asia-Pacific Celiac Disease Drugs Market Snapshot
  • 7.4.1. China Celiac Disease Drugs Market
  • 7.4.2. India Celiac Disease Drugs Market
  • 7.4.3. Japan Celiac Disease Drugs Market
  • 7.4.4. Australia Celiac Disease Drugs Market
  • 7.4.5. South Korea Celiac Disease Drugs Market
  • 7.4.6. Rest of Asia Pacific Celiac Disease Drugs Market
• 7.5. Latin America Celiac Disease Drugs Market Snapshot
  • 7.5.1. Brazil Celiac Disease Drugs Market
  • 7.5.2. Mexico Celiac Disease Drugs Market
  • 7.5.3. Rest of Latin America Celiac Disease Drugs Market
• 7.6. Rest of The World Celiac Disease Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. F. Hoffmann La Roche
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Merck & Co., Inc.
  • 8.2.3. Johnson & Johnson
  • 8.2.4. BiolineRx Ltd.
  • 8.2.5. Pfizer Inc.
  • 8.2.6. Innovate Biopharmaceuticals
  • 8.2.7. ImmusanT, Inc.
  • 8.2.8. Novartis AG
  • 8.2.9. Bristol-Myers Squibb Company
  • 8.2.10. Immunomedics, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption